IRS1 is constitutively activated in a variety of solid tumors, namely, CRC, breast cancers, leiomyomas, Wilms tumors, rhabdomyosarcomas, liposarcomas, leiomyosarcomas, and adrenal cortical carcinomas (48). Here, IRS1 is linked to breast cancer.